{"id":5482,"date":"2023-05-23T16:56:39","date_gmt":"2023-05-23T16:56:39","guid":{"rendered":"https:\/\/founderlodge.com\/latest-news\/?p=5482"},"modified":"2023-05-23T16:56:40","modified_gmt":"2023-05-23T16:56:40","slug":"myeloid-therapeutics-raises-73-million-in-funding-to-advance-novel-mrna-immunotherapy-pipeline-for-cancer-treatment","status":"publish","type":"post","link":"https:\/\/founderlodge.com\/latest-news\/myeloid-therapeutics-raises-73-million-in-funding-to-advance-novel-mrna-immunotherapy-pipeline-for-cancer-treatment\/","title":{"rendered":"Myeloid Therapeutics Raises $73 Million in Funding to Advance Novel mRNA-Immunotherapy Pipeline for Cancer Treatment."},"content":{"rendered":"\n<figure class=\"wp-block-image size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/05\/image-266.png\" alt=\"\" class=\"wp-image-5483\" width=\"218\" height=\"86\" srcset=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/05\/image-266.png 356w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/05\/image-266-300x119.png 300w\" sizes=\"(max-width: 218px) 100vw, 218px\" \/><\/figure>\n\n\n\n<p>Cambridge, Massachusetts &#8211; <a href=\"https:\/\/myeloidtx.com\/\">Myeloid Therapeutics<\/a>, a leading biotechnology company specializing in advanced gene and cell therapies, announced today that it has successfully raised $73 million in a recent funding round. The investment will accelerate the development of Myeloid&#8217;s innovative mRNA-immunotherapy pipeline, aimed at revolutionizing cancer treatment.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"446\" src=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/05\/image-267-1024x446.png\" alt=\"\" class=\"wp-image-5484\" srcset=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/05\/image-267-1024x446.png 1024w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/05\/image-267-300x131.png 300w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/05\/image-267-768x334.png 768w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/05\/image-267.png 1355w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>The funding round was led by prominent venture capital firms <a href=\"https:\/\/www.hatterasvp.com\/\">Hatteras Venture Partners<\/a>, <a href=\"https:\/\/www.8vc.com\/\">8VC<\/a>, <a href=\"https:\/\/www.archventure.com\/\">ARCH Venture Partners<\/a>, and <a href=\"https:\/\/www.newpath.partners\/\">Newpath Partners<\/a>. These strategic investors recognize the transformative potential of Myeloid Therapeutics&#8217; cutting-edge technologies and the significant impact they can have in the field of biotechnology.<\/p>\n\n\n\n<p>Myeloid Therapeutics is founded on the expertise and vision of its Co-Founder, <a href=\"https:\/\/www.linkedin.com\/in\/danielgetts\/\">Daniel G.<\/a>, and his team. Leveraging their extensive knowledge and experience in gene and cell therapies, Myeloid Therapeutics has developed novel platform technologies that harness the inherent capabilities of myeloid cells. These unique therapies promise breakthrough treatments for various types of cancer.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"482\" src=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/05\/image-268-1024x482.png\" alt=\"\" class=\"wp-image-5485\" srcset=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/05\/image-268-1024x482.png 1024w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/05\/image-268-300x141.png 300w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/05\/image-268-768x362.png 768w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/05\/image-268.png 1421w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>The company&#8217;s clinical-stage mRNA immunotherapy pipeline represents a paradigm shift in cancer therapeutics. By utilizing messenger RNA (mRNA) technology, Myeloid Therapeutics aims to stimulate the immune system&#8217;s response to cancer cells, enabling the body to recognize and eliminate tumors more effectively. This approach has the potential to significantly improve patient outcomes and transform the landscape of cancer treatment.<\/p>\n\n\n\n<p>The $73 million raised in this funding round will be instrumental in advancing Myeloid Therapeutics&#8217; research and development efforts. The funds will support the progression of the company&#8217;s mRNA-immunotherapy pipeline through preclinical and clinical studies and the expansion of its scientific and operational teams.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cambridge, Massachusetts &#8211; Myeloid Therapeutics, a leading biotechnology company specializing in advanced gene and cell therapies, announced today that it has successfully raised $73 million in a recent funding round. The investment will accelerate the development of Myeloid&#8217;s innovative mRNA-immunotherapy pipeline, aimed at revolutionizing cancer treatment. The funding round was led by prominent venture capital [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":5486,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":""},"categories":[2],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.2.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Myeloid Therapeutics Raises $73 Million in Funding to Advance Novel mRNA-Immunotherapy Pipeline for Cancer Treatment. - Founder Lodge Latest News<\/title>\n<meta name=\"description\" content=\"Cambridge, Massachusetts - Myeloid Therapeutics, a leading biotechnology company specializing in advanced gene and cell therapies, announced today that it\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/founderlodge.com\/latest-news\/myeloid-therapeutics-raises-73-million-in-funding-to-advance-novel-mrna-immunotherapy-pipeline-for-cancer-treatment\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Myeloid Therapeutics Raises $73 Million in Funding to Advance Novel mRNA-Immunotherapy Pipeline for Cancer Treatment. - Founder Lodge Latest News\" \/>\n<meta property=\"og:description\" content=\"Cambridge, Massachusetts - Myeloid Therapeutics, a leading biotechnology company specializing in advanced gene and cell therapies, announced today that it\" \/>\n<meta property=\"og:url\" content=\"https:\/\/founderlodge.com\/latest-news\/myeloid-therapeutics-raises-73-million-in-funding-to-advance-novel-mrna-immunotherapy-pipeline-for-cancer-treatment\/\" \/>\n<meta property=\"og:site_name\" content=\"Founder Lodge Latest News\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-23T16:56:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-23T16:56:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/05\/image-269.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1503\" \/>\n\t<meta property=\"og:image:height\" content=\"797\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"ucheezuma\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ucheezuma\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/myeloid-therapeutics-raises-73-million-in-funding-to-advance-novel-mrna-immunotherapy-pipeline-for-cancer-treatment\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/myeloid-therapeutics-raises-73-million-in-funding-to-advance-novel-mrna-immunotherapy-pipeline-for-cancer-treatment\/\"},\"author\":{\"name\":\"ucheezuma\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/2854d3c2f2bb3f7ff9ae13c649048af3\"},\"headline\":\"Myeloid Therapeutics Raises $73 Million in Funding to Advance Novel mRNA-Immunotherapy Pipeline for Cancer Treatment.\",\"datePublished\":\"2023-05-23T16:56:39+00:00\",\"dateModified\":\"2023-05-23T16:56:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/myeloid-therapeutics-raises-73-million-in-funding-to-advance-novel-mrna-immunotherapy-pipeline-for-cancer-treatment\/\"},\"wordCount\":258,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\"},\"articleSection\":[\"Daily Startup Funding News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/founderlodge.com\/latest-news\/myeloid-therapeutics-raises-73-million-in-funding-to-advance-novel-mrna-immunotherapy-pipeline-for-cancer-treatment\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/myeloid-therapeutics-raises-73-million-in-funding-to-advance-novel-mrna-immunotherapy-pipeline-for-cancer-treatment\/\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/myeloid-therapeutics-raises-73-million-in-funding-to-advance-novel-mrna-immunotherapy-pipeline-for-cancer-treatment\/\",\"name\":\"Myeloid Therapeutics Raises $73 Million in Funding to Advance Novel mRNA-Immunotherapy Pipeline for Cancer Treatment. - Founder Lodge Latest News\",\"isPartOf\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#website\"},\"datePublished\":\"2023-05-23T16:56:39+00:00\",\"dateModified\":\"2023-05-23T16:56:40+00:00\",\"description\":\"Cambridge, Massachusetts - Myeloid Therapeutics, a leading biotechnology company specializing in advanced gene and cell therapies, announced today that it\",\"breadcrumb\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/myeloid-therapeutics-raises-73-million-in-funding-to-advance-novel-mrna-immunotherapy-pipeline-for-cancer-treatment\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/founderlodge.com\/latest-news\/myeloid-therapeutics-raises-73-million-in-funding-to-advance-novel-mrna-immunotherapy-pipeline-for-cancer-treatment\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/myeloid-therapeutics-raises-73-million-in-funding-to-advance-novel-mrna-immunotherapy-pipeline-for-cancer-treatment\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/founderlodge.com\/latest-news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Myeloid Therapeutics Raises $73 Million in Funding to Advance Novel mRNA-Immunotherapy Pipeline for Cancer Treatment.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#website\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/\",\"name\":\"Founder Lodge Latest News\",\"description\":\"Get the latest updates on funding rounds and investment news for startups and businesses. Stay informed on capital raising trends and who&#039;s raising capital.\",\"publisher\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/founderlodge.com\/latest-news\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\",\"name\":\"Founder Lodge\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Founder Lodge\"},\"image\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/2854d3c2f2bb3f7ff9ae13c649048af3\",\"name\":\"ucheezuma\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ff09ab70d3a1229d484147623818e0af?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ff09ab70d3a1229d484147623818e0af?s=96&d=mm&r=g\",\"caption\":\"ucheezuma\"},\"url\":\"https:\/\/founderlodge.com\/latest-news\/author\/ucheezuma\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Myeloid Therapeutics Raises $73 Million in Funding to Advance Novel mRNA-Immunotherapy Pipeline for Cancer Treatment. - Founder Lodge Latest News","description":"Cambridge, Massachusetts - Myeloid Therapeutics, a leading biotechnology company specializing in advanced gene and cell therapies, announced today that it","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/founderlodge.com\/latest-news\/myeloid-therapeutics-raises-73-million-in-funding-to-advance-novel-mrna-immunotherapy-pipeline-for-cancer-treatment\/","og_locale":"en_US","og_type":"article","og_title":"Myeloid Therapeutics Raises $73 Million in Funding to Advance Novel mRNA-Immunotherapy Pipeline for Cancer Treatment. - Founder Lodge Latest News","og_description":"Cambridge, Massachusetts - Myeloid Therapeutics, a leading biotechnology company specializing in advanced gene and cell therapies, announced today that it","og_url":"https:\/\/founderlodge.com\/latest-news\/myeloid-therapeutics-raises-73-million-in-funding-to-advance-novel-mrna-immunotherapy-pipeline-for-cancer-treatment\/","og_site_name":"Founder Lodge Latest News","article_published_time":"2023-05-23T16:56:39+00:00","article_modified_time":"2023-05-23T16:56:40+00:00","og_image":[{"width":1503,"height":797,"url":"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/05\/image-269.png","type":"image\/png"}],"author":"ucheezuma","twitter_card":"summary_large_image","twitter_misc":{"Written by":"ucheezuma","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/founderlodge.com\/latest-news\/myeloid-therapeutics-raises-73-million-in-funding-to-advance-novel-mrna-immunotherapy-pipeline-for-cancer-treatment\/#article","isPartOf":{"@id":"https:\/\/founderlodge.com\/latest-news\/myeloid-therapeutics-raises-73-million-in-funding-to-advance-novel-mrna-immunotherapy-pipeline-for-cancer-treatment\/"},"author":{"name":"ucheezuma","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/2854d3c2f2bb3f7ff9ae13c649048af3"},"headline":"Myeloid Therapeutics Raises $73 Million in Funding to Advance Novel mRNA-Immunotherapy Pipeline for Cancer Treatment.","datePublished":"2023-05-23T16:56:39+00:00","dateModified":"2023-05-23T16:56:40+00:00","mainEntityOfPage":{"@id":"https:\/\/founderlodge.com\/latest-news\/myeloid-therapeutics-raises-73-million-in-funding-to-advance-novel-mrna-immunotherapy-pipeline-for-cancer-treatment\/"},"wordCount":258,"commentCount":0,"publisher":{"@id":"https:\/\/founderlodge.com\/latest-news\/#organization"},"articleSection":["Daily Startup Funding News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/founderlodge.com\/latest-news\/myeloid-therapeutics-raises-73-million-in-funding-to-advance-novel-mrna-immunotherapy-pipeline-for-cancer-treatment\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/founderlodge.com\/latest-news\/myeloid-therapeutics-raises-73-million-in-funding-to-advance-novel-mrna-immunotherapy-pipeline-for-cancer-treatment\/","url":"https:\/\/founderlodge.com\/latest-news\/myeloid-therapeutics-raises-73-million-in-funding-to-advance-novel-mrna-immunotherapy-pipeline-for-cancer-treatment\/","name":"Myeloid Therapeutics Raises $73 Million in Funding to Advance Novel mRNA-Immunotherapy Pipeline for Cancer Treatment. - Founder Lodge Latest News","isPartOf":{"@id":"https:\/\/founderlodge.com\/latest-news\/#website"},"datePublished":"2023-05-23T16:56:39+00:00","dateModified":"2023-05-23T16:56:40+00:00","description":"Cambridge, Massachusetts - Myeloid Therapeutics, a leading biotechnology company specializing in advanced gene and cell therapies, announced today that it","breadcrumb":{"@id":"https:\/\/founderlodge.com\/latest-news\/myeloid-therapeutics-raises-73-million-in-funding-to-advance-novel-mrna-immunotherapy-pipeline-for-cancer-treatment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/founderlodge.com\/latest-news\/myeloid-therapeutics-raises-73-million-in-funding-to-advance-novel-mrna-immunotherapy-pipeline-for-cancer-treatment\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/founderlodge.com\/latest-news\/myeloid-therapeutics-raises-73-million-in-funding-to-advance-novel-mrna-immunotherapy-pipeline-for-cancer-treatment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/founderlodge.com\/latest-news\/"},{"@type":"ListItem","position":2,"name":"Myeloid Therapeutics Raises $73 Million in Funding to Advance Novel mRNA-Immunotherapy Pipeline for Cancer Treatment."}]},{"@type":"WebSite","@id":"https:\/\/founderlodge.com\/latest-news\/#website","url":"https:\/\/founderlodge.com\/latest-news\/","name":"Founder Lodge Latest News","description":"Get the latest updates on funding rounds and investment news for startups and businesses. Stay informed on capital raising trends and who&#039;s raising capital.","publisher":{"@id":"https:\/\/founderlodge.com\/latest-news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/founderlodge.com\/latest-news\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/founderlodge.com\/latest-news\/#organization","name":"Founder Lodge","url":"https:\/\/founderlodge.com\/latest-news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Founder Lodge"},"image":{"@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/2854d3c2f2bb3f7ff9ae13c649048af3","name":"ucheezuma","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ff09ab70d3a1229d484147623818e0af?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ff09ab70d3a1229d484147623818e0af?s=96&d=mm&r=g","caption":"ucheezuma"},"url":"https:\/\/founderlodge.com\/latest-news\/author\/ucheezuma\/"}]}},"_links":{"self":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/5482"}],"collection":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/comments?post=5482"}],"version-history":[{"count":1,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/5482\/revisions"}],"predecessor-version":[{"id":5487,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/5482\/revisions\/5487"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/media\/5486"}],"wp:attachment":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/media?parent=5482"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/categories?post=5482"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/tags?post=5482"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}